Related Experiment Video
Updated: Jul 16, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Pyruvate kinase deficiency: the genotype-phenotype association
Alberto Zanella1, Elisa Fermo, Paola Bianchi
1Department of Haematology, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy. div_emat@policlinico.mi.it
Blood Reviews
|March 16, 2007
Summary
Pyruvate kinase (PK) deficiency, a common red blood cell glycolysis disorder, causes variable hemolytic anemia. Clinical severity depends on complex genetic and cellular factors beyond specific PK-LR gene mutations.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Red cell pyruvate kinase (PK) deficiency is the most common glycolytic enzyme defect.
- It causes chronic non-spherocytic hemolytic anemia, inherited as an autosomal recessive trait.
- Clinical presentation ranges from mild to severe, requiring transfusions in neonates.
Purpose of the Study:
- To explore the genotype-phenotype associations in red cell PK deficiency.
- To understand the molecular basis of variable clinical manifestations.
Main Methods:
- Analysis of PK-LR gene mutations.
- Biochemical characterization of recombinant mutant human red cell PK.
- Comparison with wild-type enzyme properties.
Main Results:
- 180 distinct PK-LR gene mutations, primarily missense, are linked to PK deficiency.
- Recombinant mutant analysis reveals effects of amino acid changes on enzyme properties.
- Clinical variability is influenced by factors beyond direct mutation effects.
Conclusions:
- Genotype-phenotype correlations in PK deficiency are complex.
- Clinical outcomes are modulated by genetic background, other enzyme polymorphisms, and splenic function.
- Further research is needed to fully elucidate disease pathogenesis.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:35Pedigree Analysis
Overview
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:15Pyruvate Oxidation
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...